Related by context. All words. (Click for frequent words.) 80 antiretroviral therapy 79 ARV therapy 76 antiretroviral treatment 74 anti retroviral therapy 74 antiretroviral ARV therapy 73 antiretroviral drugs 73 antiretroviral ARV treatment 72 antiretrovirals 70 ARV treatment 70 HAART 68 anti retroviral treatment 68 antiretroviral medication 67 antiretroviral 67 lifesaving antiretroviral treatment 67 antiretroviral medications 67 combination antiretroviral therapy 66 HIV infected 66 protease inhibitor PI 65 antiretrovirals ARVs 65 potent antiretroviral therapy 65 antiretroviral regimens 65 antiviral therapy 65 antiretroviral ARV drugs 65 Antiretroviral therapy 64 cART 64 ARVs 64 sulfadoxine pyrimethamine 64 Therapy HAART 64 anti retroviral drugs 64 NNRTI 64 PMTCT 64 antiretroviral drugs ARVs 63 Anti retroviral drugs 63 MDR TB 63 zidovudine AZT 63 viral suppression 63 single dose nevirapine 63 HIV infection 63 HAART regimen 63 protease inhibitors PIs 63 antiretroviral regimen 62 virologic failure 62 active antiretroviral therapy 62 stavudine 62 Anti retroviral therapy 62 antiretroviral treatments 62 Anti retroviral 61 anti retroviral treatments 61 receiving antiretroviral therapy 61 uncomplicated malaria 61 ARV rollout 61 CD4 counts 61 Anti Retroviral Treatment 61 cotrimoxazole 61 Anti Retroviral Therapy 61 HAART regimens 61 antiretroviral therapies 61 PrEP 61 co trimoxazole 61 HIV 61 NRTI 61 ARV drugs 60 anti retroviral ARV 60 cotrimoxazole prophylaxis 60 NNRTIs 60 virological failure 60 life prolonging antiretroviral 60 virological response 60 antiretroviral prophylaxis 60 tipranavir 60 anti retroviral therapies 60 Antiretroviral Therapy 60 antiretroviral ARV medication 60 Antiretroviral drugs 60 Anti Retro Viral 59 uncomplicated falciparum malaria 59 anti retroviral medication 59 pneumococcal vaccination 59 stavudine d4T 59 anti retroviral 59 chronic HCV infection 59 anti retroviral medications 59 Highly Active Antiretroviral 59 IPTp 59 Antiretroviral Therapy ART 59 sustained virologic response 59 Nevirapine 59 ARVS 59 Antiretrovirals 59 NRTIs 58 isoniazid 58 lamivudine 58 d4T 58 CD4 count 58 APTIVUS r 58 HIV AIDS 58 iPrEx study 58 nevirapine 58 HPTN 58 multidrug resistant tuberculosis MDR 58 CMV infection 58 routine immunization 58 Anti Retroviral drugs 58 anti retrovirals 58 anti retrovirals ARVs 58 ITNs 58 insecticide treated nets ITNs 57 Hydroxyurea 57 amodiaquine 57 Combivir 57 praziquantel 57 protease inhibitor 57 AZT 3TC 57 entecavir 57 CD4 cell 57 SIV infection 57 malaria endemic areas 57 resistant TB 57 post exposure prophylaxis 57 efavirenz Sustiva 57 pyrazinamide 57 NRTI backbone 57 MDRTB 57 TDF FTC 57 Antiretroviral 57 Antiretroviral treatment 57 pegylated interferon 57 PLHIV 57 viral loads 57 monotherapies 57 tenofovir 57 MDR tuberculosis 57 P. falciparum malaria 57 HCV infected 57 Sexually Transmitted Infections STI 57 Fansidar 57 treatment regimens 57 Kivexa 57 postexposure prophylaxis 57 Multi Drug Resistant 57 herpes infections 57 Antiretroviral ARV 57 peginterferon 57 cisplatin chemotherapy 57 viral load 56 fosamprenavir 56 d4T stavudine Zerit 56 rhGH 56 NNRTI resistance 56 IPTi 56 nucleoside analogues 56 CMV disease 56 antimicrobial prophylaxis 56 warfarin therapy 56 antiretroviral ARV 56 Antiretroviral Drugs 56 Antiretroviral Treatment 56 Isentress raltegravir 56 TB MDR TB 56 Darunavir 56 injectable contraceptives 56 HBV vaccination 56 APTIVUS 56 BCG vaccination 56 acquired immunodeficiency syndrome 56 measles vaccination 56 candidemia 56 zidovudine lamivudine 56 genital herpes infections 56 ritonavir boosted protease inhibitor 56 therapies ACTs 56 nucleoside analogue 56 ART antiretroviral therapy 56 efavirenz 56 Anti retrovirals 56 pyrimethamine 56 sustained virological response 56 hepatitis C genotype 56 virologic suppression 56 Hib vaccination 56 chemoprophylaxis 56 HIV infections 56 tamoxifen therapy 56 Valcyte 56 Acquired Immunodeficiency Syndrome 56 Tuberculosis TB 56 peg interferon 56 lipid lowering therapy 55 anti malarial medicines 55 malaria endemic countries 55 HIV AIDS PLWHA 55 HBV infection 55 virologically 55 HBeAg negative 55 HIV AIDS sufferers 55 malaria endemic 55 ribavirin 55 Short Course DOTS 55 PCV7 55 nevirapine Viramune 55 sulphadoxine pyrimethamine 55 Anti Retroviral 55 nelfinavir 55 ISENTRESS 55 adalimumab 55 REYATAZ 55 pegylated interferon alpha 55 HIB vaccine 55 tenofovir emtricitabine 55 hepatitis B vaccination 55 diarrheal deaths 55 lopinavir ritonavir Kaletra 55 tenofovir DF 55 relapsed MM 55 HCV infections 55 PLWAs 55 HIV PLHIV 55 N. gonorrhoeae 55 ethambutol 55 Artesunate 55 undetectable viral load 55 Immunization EPI 55 efavirenz emtricitabine 55 Influenza vaccination 55 virologic response 55 therapeutic regimens 55 trastuzumab Herceptin ® 55 MYCAMINE 55 suppressive therapy 55 BARACLUDE 55 iron supplementation 55 ARV regimen 55 monovalent vaccine 55 raltegravir 55 HIV Aids epidemic 55 wild poliovirus 55 anti retroviral therapy HAART 55 ARV regimens 55 antiretroviral medicines 55 measles vaccinations 55 anti malarial drugs 55 nevirapine NVP 55 rotavirus vaccination 55 INTELENCE 55 ART regimens 55 HIV TB coinfection 55 darunavir 54 WHO UNAIDS 54 antiepileptic drugs 54 Guerma 54 canakinumab 54 HIV Aids 54 AZT zidovudine Retrovir 54 Viramune 54 microbicide trials 54 meningococcal vaccines 54 bOPV 54 LEXIVA r 54 tenofovir Viread 54 chemotherapeutic regimen 54 cryptococcal meningitis 54 HCV infection 54 nitazoxanide 54 virologic responses 54 co trimoxazole prophylaxis 54 integrase inhibitor 54 HIV prevalence 54 discordant couples 54 Co trimoxazole 54 APTIVUS ritonavir 54 P. vivax malaria 54 ribavirin therapy 54 chloroquine 54 PREZISTA r 54 tuberculin skin testing 54 rifapentine 54 Merck Isentress 54 Immunisation Programme 54 antidepressant therapy 54 CCR5 antagonist 54 insecticide treated bednets 54 malaria endemic regions 54 dose Nevirapine 54 mOPV1 54 chronically infected 54 ritonavir boosted 54 docetaxel chemotherapy 54 estrogen progestin therapy 54 pentavalent vaccine 54 sulphadoxine pyrimethamine SP 54 valacyclovir 54 fluoroquinolone resistance 54 zidovudine 54 virologic 54 generalized epidemics 54 antituberculosis drugs 54 enfuvirtide 54 antimalarial medicines 54 APTIVUS R 54 Edurant 54 AZT 54 drugs isoniazid 54 exemestane 54 Tuberculosis MDR TB 54 BEACOPP 54 artemesinin 54 lopinavir 54 Amodiaquine 54 rotavirus diarrhea 54 poliovirus vaccine 54 topotecan 54 disease progression 54 opportunistic infections 54 statin therapy 54 boosted protease inhibitor 54 pertussis vaccination 54 monotherapy 54 amoxicillin clavulanate 54 Pegasys plus Copegus 54 glatiramer acetate 54 LLINs 54 artemisinins 54 Pegylated Interferon 54 chlamydial infection 54 AGILECT R 53 Hepatitis B vaccination 53 leukemia ALL 53 measles immunizations 53 Epivir 53 Simelela 53 varicella vaccination 53 tuberculosis TB 53 albendazole 53 Cotrimoxazole 53 antihypertensive therapy 53 saquinavir ritonavir 53 BARACLUDE ® 53 genotypic resistance 53 diarrheal disease 53 lamivudine 3TC 53 artesunate 53 DAPT 53 darunavir ritonavir 53 fluconazole 53 Pap smear screening 53 mRCC 53 prophylaxis 53 COMBIVIR 53 lamivudine zidovudine 53 MTCT 53 vWD 53 generalized epidemic 53 measles vaccination campaign 53 nucleoside analog 53 COREG 53 Hepatitis B vaccine 53 sunitinib 53 polysaccharide vaccine 53 saquinavir 53 Highly Active 53 Anti Retroviral ARV 53 DMARD therapy 53 insecticide treated mosquito nets 53 HIV HCV coinfected 53 receiving VICTRELIS 53 seroprevalence 53 standard chemotherapy regimen 53 maraviroc 53 antimalarial drugs 53 Gag polymorphisms 53 RNTCP 53 artemisinin derivative 53 interferon ribavirin 53 Sexually Transmitted Infections STIs 53 atazanavir 53 exclusive breastfeeding 53 lopinavir ritonavir 53 Lapdap 53 VICTRELIS 53 MMRV vaccine 53 proguanil 53 abacavir 53 pneumococcal conjugate vaccine 53 pegylated interferon alfa 53 Triomune 53 nucleotide analog 53 ZYVOX 53 polio immunization campaigns 53 azathioprine 53 cholinesterase inhibitor 53 dose regimen 53 virological suppression 53 undetectable viral loads 53 intravenous bisphosphonates 53 GnRH agonists 53 HIV seroconversion 53 Coartem 53 Hib disease 53 daunorubicin 53 Decitabine 53 Vaginal gel 53 hydroxychloroquine 53 Routine immunization 53 long lasting insecticidal 53 malaria prophylaxis 53 nonnucleoside reverse transcriptase inhibitors 53 polioviruses 53 ofpatients 53 3TC lamivudine Epivir 53 lifesaving antiretroviral 53 dexamethasone Decadron 53 SUTENT 53 chronic HCV 53 HCV genotype 1 53 chronic HBV 53 lenalidomide Revlimid R 53 chemoradiotherapy 53 placental malaria 53 virologic breakthrough 53 antifungal therapy 53 Etravirine 53 inhibit replication 53 indinavir 53 miglustat 53 TYGACIL 53 Chloroquine 53 HIV prevention 53 adefovir 53 slow progressors 53 generic ARVs 53 aldosterone antagonists 53 CAELYX 53 DMARD 53 protease inhibitors 53 chemotherapy regimens 53 Combination therapy 53 multidrug resistant MDR TB 53 imatinib 53 antiviral prophylaxis 53 chronic hemodialysis 53 HER2 positive breast cancer 53 tipranavir ritonavir 53 hepatitis C HCV 53 dapsone 52 pre exposure prophylaxis 52 falciparum malaria 52 Anti Retroviral Drugs 52 peginterferon alfa 2a 52 CANCIDAS 52 pyridostigmine 52 artemisinin combination 52 Zidovudine 52 Cohort Study MACS 52 abacavir lamivudine 52 vaginal microbicides 52 antithrombotic therapy 52 relapsing MS 52 cabazitaxel 52 Hepatocellular Carcinoma HCC 52 VIRAMUNE XR 52 OIs 52 idarubicin 52 renal flares 52 Velcade bortezomib 52 insomnia sufferers 52 LPV r 52 Oral Polio Vaccine 52 drugs tenofovir lamivudine 52 Natalizumab 52 LTBI 52 Tenofovir 52 PREZISTA ™ 52 nucleoside reverse transcriptase inhibitors 52 atypical antipsychotic medications 52 micronutrient supplementation 52 neonatal mortality 52 acid suppressive medications 52 multivitamin supplementation 52 metformin 52 adjuvant tamoxifen 52 Exclusive breastfeeding 52 falciparum 52 iPrEx 52 low dose ritonavir 52 ganciclovir 52 valent pneumococcal conjugate vaccine 52 rehydration therapy 52 PREZISTA 52 revaccination 52 BRAF mutation 52 metastatic lung cancer 52 BEXXAR therapeutic regimen 52 HIV AIDS epidemic 52 impregnated mosquito nets 52 octreotide LAR 52 Pneumococcal vaccines 52 immunosuppressive agents 52 clodronate 52 Testing VCT 52 anastrozole 52 immunosuppressive regimens 52 decitabine 52 apricitabine 52 experienced virologic failure 52 VIRAMUNE 52 insecticide treated nets 52 immunomodulatory therapy 52 perinatal transmission 52 RDTs 52 severe rotavirus gastroenteritis 52 docetaxel 52 valganciclovir 52 UNAids 52 varicella vaccine 52 oseltamivir Tamiflu 52 HBV DNA 52 HIV seronegative 52 HIV Aids prevalence 52 tenofovir FTC 52 placebo dexamethasone 52 bisphosphonate therapy 52 sentinel surveillance 52 REYATAZ ritonavir 52 pneumococcal infection 52 Hib meningitis 52 Aptivus 52 Soliris therapy 52 Entecavir 52 CCR5 tropic HIV 52 artemether 52 Artemisinin 52 Nelfinavir 52 antiretroviral naive 52 isoniazid preventive therapy 52 chemotherapeutic regimens 52 invasive candidiasis 52 corticosteroid therapy 52 taxane chemotherapy 52 oral FTY# 52 antiretroviral naïve 52 CHOP chemotherapy 52 RRMS patients 52 antibiotic prophylaxis 52 mycophenolate mofetil 52 Chlamydia infections 52 Twinrix 52 inactivated poliovirus vaccine 52 anti retroviral medicines 52 venous blood clots 52 lifesaving antiretroviral drugs 52 BCG vaccine 52 pharmacologic intervention 52 Antiviral drugs 52 malaria diarrheal diseases 52 ribavirin RBV 52 pegfilgrastim 52 anticoagulation therapy 52 abiraterone 52 multidrug resistant strains 52 malaria 52 Prophylaxis 52 rifabutin 52 artemether lumefantrine 52 child transmission PMTCT 52 serologic testing 52 invasive MRSA infections 52 darunavir r 52 gonococcal infections 52 nephrotoxic drugs 52 TMP SMX 52 Isoniazid 52 alfa 2a 52 recurrent VTE 52 combination therapies ACTs 52 FTC TDF 52 FROVA 52 aromatase inhibitor therapy 52 imipenem 52 pneumococcal pneumonia 52 antimalarials 52 HIVAN 52 Immunisation EPI 51 oral antidiabetes drugs 51 bednets 51 sulfadoxine 51 Anti malarial 51 superficial bladder cancer 51 retroviral therapy 51 Rift Valley Fever RVF 51 MULTAQ 51 retrovirals 51 empiric treatment 51 Coalition ITPC 51 transgenic rats 51 Protease inhibitors 51 pimozide 51 invasive fungal infections 51 NACP III 51 disease modifying antirheumatic 51 multivitamin supplements 51 comparator PI r 51 buprenorphine naloxone 51 hepatitis C virus 51 M#V mutation 51 antimalarial 51 antihypertensive drugs 51 mitoxantrone 51 Malaria Vaccine Initiative MVI 51 β blocker 51 recurrent genital herpes 51 Liver transplantation 51 Peg IFN 51 immunosuppressed patients 51 Maraviroc 51 trastuzumab 51 REYATAZ ® 51 lapatinib Tykerb 51 child transmission MTCT 51 Combination antiretroviral therapy 51 VIDAZA 51 lupus nephritis 51 anti malarials 51 ibandronate 51 transcriptase inhibitor NNRTI 51 TroVax ® 51 cytomegalovirus infection 51 etravirine 51 Didanosine 51 complete cytogenetic response 51 HeFT 51 antiepileptic drugs AEDs 51 herpes zoster vaccine 51 nucleotide analogue 51 Abacavir 51 macrolide antibiotics 51 CD4 + cell 51 Oral Polio Vaccine OPV 51 folate supplementation 51 latent tuberculosis infection 51 basal cell nevus syndrome 51 AIDS 51 antidiabetic therapy 51 trivalent vaccine 51 severe acute malnutrition 51 nucleoside reverse transcriptase inhibitor 51 rectal gonorrhea 51 vicriviroc 51 heavily pretreated 51 GeoVax vaccine 51 ritonavir boosted lopinavir 51 severely immunocompromised patients 51 nucleoside naive patients 51 ARVs antiretroviral drugs 51 ALT flares 51 users IDUs 51 coinfection 51 rindopepimut 51 analgesic medications 51 metastatic RCC 51 forodesine 51 coinfected patients 51 lipid lowering drugs 51 suboptimal adherence 51 SCIg 51 KETEK 51 nephrotoxic agent 51 atazanavir ritonavir 51 Prezista darunavir 51 chikungunya virus 51 Raltegravir 51 Reverset 51 anti malarial drug 51 Pentavalent vaccine 51 Hepatitis B virus 51 serum HBV DNA 51 lumefantrine 51 doxorubicin docetaxel 51 HSCT 51 ADAP waiting 51 Pneumococcal Vaccine 51 primaquine 51 C. difficile infections 51 AZOR 51 peg IFN 51 relapsed AML 51 relapsing remitting MS RRMS 51 trials RCTs 51 CsA 51 latent tuberculosis 51 Rifampicin 51 C. difficile infection 51 antibiotic regimens 51 sunitinib malate 51 seroconversion 51 Male circumcision 51 treated bednets 51 Fuzeon enfuvirtide 51 drug resistant strains 51 anti retroviral ARVs 51 CAPRISA 51 cytogenetic response 51 Torisel 51 antiplatelet therapy 51 Vacc 4x 51 antenatal clinics 51 HIV sero 51 viral kinetics 51 antiepileptic drug 51 antibiotic azithromycin 51 ARVs antiretrovirals 51 antenatal care 51 H.I.V. 51 liver transplantation 51 BEXXAR Therapeutic Regimen 51 androgen deprivation 51 unimmunised 51 measles immunization 51 Kala azar 51 EPZICOM 51 prolonging anti retroviral 51 antimalarial treatments 51 PLHA 51 invasive aspergillosis 51 hydroxyurea 51 Viral load 51 divalproex sodium 51 Mylotarg 51 serum clusterin levels 51 Sustiva efavirenz 51 IDUs 51 antiandrogen 51 reperfusion therapy 51 genital ulcer disease 51 piperacillin tazobactam 51 Gilead Truvada 51 antioxidant supplementation 51 Candida species 51 indinavir Crixivan 51 SELZENTRY 51 Sleeping sickness 51 pneumococcal vaccines 51 gout flares 51 hepatitis B infection 51 undetectable HCV RNA 51 Acquired Immune Deficiency Syndrome 51 trimethoprim sulfamethoxazole 51 methotrexate therapy 51 thiazide diuretic 51 metastatic kidney 51 bendamustine 51 micronutrient supplements 51 HBeAg 51 Programme RNTCP 51 multidrug resistant TB MDR 51 bacteraemia 51 HCV 51 neonatal circumcision 51 seasonal influenza vaccination 51 Celsentri Selzentry 51 Human Immuno deficiency 51 standard chemotherapy regimens 51 RTS S/AS# 51 anti TNFs 51 CCR5 inhibitor 51 REVLIMID ® 51 XDR tuberculosis 51 cytotoxic therapy 51 abacavir Ziagen 51 INFERGEN 51 tetanus vaccination 51 Tindamax R 51 Fludara 51 glycosylated hemoglobin levels 51 Zerit 51 HIV Aids sufferers 51 SIV infected 51 PegIFN RBV 51 ChronVac C ® 51 DMARDs 51 insulin detemir 51 Lamictal XR 51 opioid substitution 51 exemestane Aromasin 51 clinically evaluable 51 nonmelanoma skin cancers 51 Neglected Tropical Diseases NTDs 51 Norvir ritonavir 51 antihypertensive medications 50 beta blocker therapy 50 pegylated interferon alfa 2a 50 7 valent pneumococcal 50 drug resistant TB 50 NRTI resistance 50 zinc supplementation 50 Cethromycin 50 chemotherapy regimen 50 Raptiva r 50 PREVENAR 50 Tenofovir Disoproxil Fumarate 50 ß blockers 50 TB bacillus 50 tamoxifen Nolvadex 50 Prezista 50 cytotoxic chemotherapy 50 regimens 50 sorafenib 50 tamoxifen 50 VIRAMUNE R 50 acute GvHD 50 MenAfriVac 50 systemic fungal infections 50 chlamydial 50 rituximab 50 log# reduction 50 CHAMPION PCI 50 indoor residual spraying 50 HIV AIDs 50 dose cytarabine 50 acute STEMI 50 dosage regimens 50 COPAXONE ® 50 quinolone 50 NTDs 50 COPAXONE R 50 acromegalic patients 50 TORISEL 50 SECURE THE FUTURE 50 Virus HIV 50 seroconverted 50 AZT zidovudine 50 HBV DNA levels 50 paricalcitol 50 Trastuzumab 50 Protease inhibitor 50 REYATAZ R 50 cytarabine 50 imatinib therapy 50 NNRTI resistant virus 50 Tenofovir gel 50 Stavudine 50 maternal morbidity 50 lipid lowering medications 50 antibiotic therapy 50 AIDS Clinical Trials 50 neutropenic patients 50 #mg/day [001] 50 non nucleoside reverse 50 Marburg haemorrhagic fever 50 TMC# C# 50 cytoreduction 50 ceftriaxone 50 sputum microscopy 50 cellulose sulfate 50 liver transplantations 50 ICD therapy 50 meningococcal conjugate vaccine 50 Copegus ribavirin 50 tetanus immunization 50 eculizumab therapy 50 temozolomide 50 amphotericin B 50 adalimumab Humira 50 latent TB infection 50 artemisinin resistance 50 HCV genotypes 50 SJIA 50 C difficile infection 50 antituberculosis 50 Ribavirin 50 FIRMAGON 50 oral poliovirus 50 HIV coinfected 50 5-FU/LV 50 HIVAIDS 50 efavirenz EFV 50 HIV uninfected 50 NOMID 50 Resistant TB 50 ARV 50 oral contraceptive pills 50 transcriptase inhibitors NNRTIs 50 PPSV# 50 eosinophilic asthma 50 Retreatment 50 RSV infections 50 diagnosed GBM 50 PREZISTA ritonavir 50 Plasmodium falciparum malaria 50 ivabradine 50 Sexually Transmitted Infections 50 retroviral 50 Rifampin 50 colorectal cancer CRC 50 Lamivudine 50 ARV anti retroviral 50 Deworming 50 aciclovir 50 rilpivirine 50 bivalent vaccine 50 oral rehydration therapy 50 null responder HCV 50 Artemether 50 letrozole Femara 50 palivizumab 50 LCMV infection 50 Pegasys ® 50 IRESSA 50 serotype #A 50 HIV AIDS pandemic 50 anti malarial medication 50 Cloretazine 50 human immunodeficiency virus 50 LYSTEDA 50 venous thromboembolic events 50 NAbs 50 spironolactone 50 symptomatic BPH 50 NOXAFIL 50 AIDS UNAIDS 50 flutamide 50 MTCT Plus 50 onchocerciasis 50 BEXXAR 50 conjugate vaccine 50 Pneumococcal vaccine 50 Lamivudine Zidovudine 50 polysaccharide vaccines 50 diphtheria pertussis whooping cough 50 radioiodine therapy 50 TMC# [001] 50 virus HBV 50 Hb A1C 50 PLWHA 50 Dose escalation 50 intensive statin therapy 50 HIV seropositive 50 mebendazole 50 lifesaving anti retroviral 50 measles vaccination campaigns 50 carvedilol 50 Paromomycin IM Injection 50 triple nucleoside 50 Follicular Lymphoma 50 S. aureus colonization 50 atazanavir Reyataz 50 ddI 50 indoor insecticide spraying 50 tenofovir gel 50 Aids pandemic 50 Pegasys peginterferon alfa 2a 50 dengue viruses 50 thromboprophylaxis 50 antidiabetic medication 50 anagrelide 50 argatroban 50 chemotherapy docetaxel 50 AMPATH 50 Trypanosomiasis 50 thrombolytic therapy 50 anti TNF 50 Pneumonia vaccine 50 lenalidomide dexamethasone 50 febrile seizure 50 moderately malnourished children 50 Saquinavir 50 EBV infection 50 Regimens 50 OHR/AVR# 50 aldosterone antagonist 50 schistosomiasis 50 FUZEON 50 HbA 1c levels 50 Efavirenz 50 hour bronchodilation 50 artesunate amodiaquine 50 lamivudine Epivir 50 surface antigen HBsAg 50 intracranial hemorrhage ICH 50 Hib vaccines 50 anticonvulsant drugs 50 Moxifloxacin 50 cat dander allergy 50 Anaemia 50 cidofovir 50 immunosuppression 50 statin 50 RhD negative 50 evaluating tivozanib 50 clinical pharmacology studies 50 CCR5 inhibitors 50 Naive Patients 50 Femara letrozole 50 Selzentry 50 rFVIIa 50 AIDS epidemic 50 nucleoside 50 Kaposi Sarcoma 50 statins 50 AIDS pandemic